VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion.
Fiche publication
Date publication
août 2018
Journal
Stem cell reviews and reports
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LAHLIL Rachid, Dr BARBET Romain
Tous les auteurs :
Lahlil R, Scrofani M, Barbet R, Tancredi C, Aries A, Hénon P
Lien Pubmed
Résumé
The very small embryonic-like stem cells (VSELs) are known as a subset of adult pluripotent stem cells able to differentiate to all three germ layers. However, their small number and quiescence restrict the possibility of their use in cell therapy. In the present study, we first delineate different subpopulation of VSELs from human cord blood CD34+ cells to define their purity. We next determine genes expression levels in the whole transcriptome of VSELs expressing the pluripotent marker NANOG and control cells under the steady state condition. We found that more than a thousand of genes are downregulated in VSELs, as well as many membrane receptors, cells signaling molecules and CDKs mRNAs. In addition, we observed discordance in some pluripotent genes expression levels with embryonic stem cells (ESCs), which could explain VSELs quiescence. We then evaluate VSELs capacity to expand and differentiate in vitro in specific and appropriate media. After 12 days culture in specific medium containing a pyrimidoindole derivative (UM171), VSELs were significantly expanded for the first time without feeder cells and importantly preserve their capacities to differentiate into hematopoietic and endothelial cells. Interestingly, this stimulation of VSELs self-renewal restores the expression of some downregulated genes known as key regulators of cell proliferation and differentiation. The properties of such pluripotent expanded cells make them a potential candidate in regenerative medicine.
Mots clés
CD34+/CD133+/CXCR4+ cells, Human very small embryonic-like stem cells, NANOG, UM171, Umbilical cord blood, VSELs
Référence
Stem Cell Rev Rep. 2018 Aug;14(4):510-524